TERT and neoplasm: Several investigators have shown that TERT promoter mutations are significantly more common among older patients, bigger tumor size, more aggressive subtype, tumors with extrathyroidal invasion, distant metastasis or higher stage at diagnosis, and are related to poor outcomes [7,23,24,25,26,27,28].